Constellation: MorphoSys : Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals (Form 6-K)

(marketscreener.com) developed by Janssen Research & Development, LLC and marketed by Janssen Biotech, Inc., for the treatment of plaque psoriasis - became the first drug based on MorphoSys' antibody technology to receive regulatory approval. In July 2020, the U.S. Food and Drug Administration granted accelerated approval of the company's proprietary product Monjuvi ...https://www.marketscreener.com/quote/stock/MORPHOSYS-AG-436425/news/MorphoSys-nbsp-Announces-Expiration-of-the-Hart-Scott-Rodino-Waiting-Period-for-Acquisition-of-Con-35769251/?utm_medium=RSS&utm_content=20210701